HCAT
Health Catalyst, Inc.
$2.29
+0.00 (+0.00%)
At close · Jul 13
Market Cap
$169.22M
Shares
73,894,020
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$311.14M
+1.5%
FY2025
Net Income
-$177.97M
-156.1%
FY2025
Operating Margin
-51.7%
-28.9pp
FY2025
Diluted EPS
-$2.55
-121.7%
FY2025
Operating Cash Flow
$731K
-95%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $260M – $265M | $302.48M | $311.14M | $306.58M | $295.94M | $276.24M | $241.93M | $188.85M | $154.94M | $112.57M | $73.08M | |
| — | $44.36M | $49.77M | $57.95M | $72.63M | $75.68M | $62.73M | $53.52M | $46.25M | $38.59M | $28.47M | |
| — | $48.32M | $52.48M | $54.39M | $67.32M | $87.51M | $75.03M | $55.41M | $47.28M | $44.12M | $25.92M | |
| — | $49.36M | $49.56M | $56.82M | $76.56M | $61.7M | $85.93M | $59.24M | $31.71M | $22.69M | $14.7M | |
| — | $34.9M | $35.5M | $28.7M | $29.6M | $37.2M | $32M | $15.9M | $6.3M | $5.1M | $4.5M | |
| — | $50.3M | $50.5M | $41.43M | $42.22M | $48.3M | $37.53M | $18.73M | $9.21M | $7.41M | $5.89M | |
| — | $398.06M | $312.53M | $210.59M | $258.73M | $273.19M | $261.22M | $186.89M | $134.46M | $112.82M | $74.98M | |
| — | -$247.16M | -$160.85M | -$69.81M | -$126.9M | -$140.01M | -$143.65M | -$96.13M | -$54.87M | -$60.1M | -$45.54M | |
| — | — | -51.7% | -22.77% | -42.88% | -50.68% | -59.38% | -50.9% | -35.41% | -53.38% | -62.31% | |
| — | -$196.87M | -$110.35M | -$28.38M | -$84.67M | -$91.71M | -$106.12M | -$77.4M | -$45.65M | -$52.68M | -$39.65M | |
| — | — | -$177.26M | -$69.17M | -$117.79M | — | — | — | — | — | — | |
| — | $915K | $716K | $333K | $356K | -$4.28M | -$6.9M | -$1.19M | $142K | -$135K | $26K | |
| — | -$265.26M | -$177.97M | -$69.5M | -$118.15M | -$137.4M | -$153.21M | -$115.02M | -$60.1M | -$61.98M | -$47.04M | |
| — | — | -57.2% | -22.67% | -39.92% | -49.74% | -63.33% | -60.91% | -38.79% | -55.06% | -64.36% | |
| — | -$265.26M | -$177.97M | -$69.5M | -$118.15M | -$137.4M | -$153.21M | -$115.02M | -$240.92M | -$114.02M | -$58.78M | |
| — | -$264.39M | -$175.55M | -$70.37M | -$117.47M | -$137.98M | -$153.34M | -$115.03M | -$60.02M | -$61.97M | -$47.02M | |
| USD/shares | — | — | -$2.55 | -$1.15 | -$2.09 | -$2.56 | -$3.23 | -$2.91 | -$12.86 | — | — |
| USD/shares | — | — | -$2.55 | -$1.15 | -$2.09 | -$2.63 | -$3.23 | -$2.91 | -$12.86 | — | — |
| shares | — | — | 69.9M | 60.18M | 56.42M | 53.72M | 47.49M | 39.54M | 18.74M | 4.8M | 4.85M |
| shares | — | — | 69.9M | 60.18M | 56.42M | 54.08M | 47.49M | 39.54M | 18.74M | 4.8M | 4.85M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2017–FY2025: $23.91M in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
0.87×
Health Information Services median 1.34×
EV/EBIT
—
Health Information Services median 25.06×
P/E (TTM)
—
Health Information Services median 33.12×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Technology | $208,277,000 | $194,852,000 | $187,583,000 | $176,288,000 | $147,718,000 | $110,467,000 | $83,975,000 | $57,224,000 |
| Professional Services | $102,859,000 | $111,732,000 | $108,355,000 | $99,948,000 | $94,208,000 | $78,378,000 | $70,966,000 | $55,350,000 |
By Product & Service (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Recurring Technology | $208,277,000 | $194,852,000 | $187,226,000 | $175,808,000 | $147,446,000 | $110,467,000 | $83,791,000 | $55,266,000 |
| Technology | $208,277,000 | $194,852,000 | $187,583,000 | $176,288,000 | $147,718,000 | $110,467,000 | $83,975,000 | $57,224,000 |
| Professional Services | $102,859,000 | $111,732,000 | $108,355,000 | $99,948,000 | $94,208,000 | $78,378,000 | $70,966,000 | $55,350,000 |
| Onetime Technology | $0 | $0 | $357,000 | $480,000 | $272,000 | $0 | $184,000 | $1,958,000 |